XNYS · MRK
-0.09% · -$0.1200 · Vol 13.5M
Market closed · last close 4:00 PM ET · price as of 19:59:50 ET
Merck & Co., Inc.

Merck & Co., Inc.

PHARMACEUTICAL PREPARATIONS
$127.51
Card
Relationship Map

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
HISTORY WINDOW BUILDING
AI Analysis
Sovereign

Why is MRK moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for MRK are being assembled.
About Merck & Co., Inc.
PHARMACEUTICAL PREPARATIONS
Listed since
1949
Employees
75K
Country
US

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$128.45
Day high
$131.74
Day low
$127.03
Previous close
$127.63
52W high
$131.74
-3.21% from high
52W low
$77.60
92% of range
Market cap
$314.9B
Beta
0.03
Shares out
2.5B
Volume
13.5M
1.15× rel vol
Avg volume
11.7M
VWAP
$128.94
Price history computed in-house
1W
+2.81%
1M
+11.98%
3M
+13.28%
1Y
+59.47%
YTD
+21.14%
SMA 50 $119.52 · above
SMA 200 $109.50 · above
52W position 92%
Veridion warehouse edge

Warehouse intelligence for MRK.

Veridion Score
61
Checking plan access.
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Related public evidence

Continue the MRK research trail.

Relationship mapTrace receipt-backed holders and filings around MRK.Congress disclosuresOpen receipt and filing context for MRK.MethodologyReview score inputs, coverage rules, and limitations.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

Receipt-backed filing rows for MRK are being assembled from the latest scheduled snapshot.

Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

MRK contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MRK in this window.
Lobbying spend

MRK lobbying filings, year to date.

Registered lobbying filings matched to Merck & Co., Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MRK in this window.
Latest news · MRK
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for MRK.
Options
Sovereign unlock shows live options positioning for MRK.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.